Buccal swab technology complements existing collection approaches, enabling broader participation in population genomics SAN MATEO, Calif. and PLEASANTON, CalifBuccal swab technology complements existing collection approaches, enabling broader participation in population genomics SAN MATEO, Calif. and PLEASANTON, Calif

Helix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample Collection

2026/02/10 22:45
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Buccal swab technology complements existing collection approaches, enabling broader participation in population genomics

SAN MATEO, Calif. and PLEASANTON, Calif., Feb. 10, 2026 /PRNewswire/ — Helix, the leading enterprise genomics company, has partnered with Mawi DNA Technologies, a leader in DNA sample collection and storage, to expand access to non-invasive DNA collection for genomic sequencing. The collaboration enhances Helix’s ability to reach new patient populations while maintaining a flexible, multimodal approach to population genomics.

Mawi has developed buccal collection technology, which involves swabbing cells from the inside of a participant’s cheek for analysis. The approach is quick, painless, easy to administer, and designed to improve collection efficiency while reducing resampling, failure rates, and overall operational costs.

Helix supports multiple DNA collection methods, including blood, saliva, and now buccal swabs, recognizing that no single approach is optimal for every individual or use case. While saliva-based collection is widely used, it may present challenges for some individuals – such as infants, older adults, or people with certain chronic conditions that affect saliva production. Buccal swabs offer an additional option that can help ensure more consistent sample collection.

“By adding buccal swab collection to our existing blood and saliva options, we give our partners greater flexibility to design programs that work for their specific populations and settings,” said James Lu, M.D., Ph.D., CEO of Helix. “This multimodal approach helps increase participation and generate high-quality genomic data that can drive meaningful clinical and research insights.”

By incorporating Mawi’s buccal collection technology, Helix will further strengthen its sequencing programs by improving collection flexibility and supporting more consistent data generation across diverse cohorts. The partnership enables Helix to meet the needs of health systems and life sciences partners by offering multiple validated pathways for high-quality genomic data.

“We are thrilled that Helix has selected Mawi’s sample collection technology as an important component of their global effort to understand population genomics on a large scale,” said Dr. Bassam El-Fahmawi, CEO and Chief Technical Officer of Mawi DNA. “This initiative aligns with our mission of enabling sample collection accessibility from any individual regardless of age or geographical location. Global sample diversity is critical for a better holistic perspective of understanding genetic diseases and their effects on overall health and wellness across different communities around the world.”

About Helix:
Helix is the leading enterprise genomics platform. The company transforms health systems and enables life science organizations to leverage the power of genomics across their enterprise, creating strategic value and fueling future growth. The Helix Research Network® – North America’s largest precision health network – accelerates genomic discoveries and translates them into real-world clinical impact. Learn more at www.helix.com.

Helix Media Contact:
[email protected] 

About Mawi DNA
Mawi DNA Technologies, founded in 2013, has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples. Mawi’s mission is to uphold sample integrity from anywhere in the world at room temperature, enabling true sample diversity across any geography or population segment. The company’s flagship product iSWAB-DNA is the only sample collection product on the market proven to produce a high quality DNA sample with low bacterial DNA content. Mawi also supplies products for collection of RNA, microbiome, intact cells, and whole blood. At Mawi, The Future of Biosampling is Here™. For more information, visit http://www.mawidna.com.

Mawi Media Contact: 
Jerome David
[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/helix-partners-with-mawi-dna-technologies-to-expand-access-to-non-invasive-genomic-sample-collection-302683441.html

SOURCE Helix

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Aster Document Update: ASTER token holders will enjoy a 5% discount on perpetual contract trading fees

Aster Document Update: ASTER token holders will enjoy a 5% discount on perpetual contract trading fees

PANews reported on September 22 that according to market news, Aster documents have been updated, stating that holders of ASTER tokens will enjoy a 5% fee discount on perpetual contract transactions.
Share
PANews2025/09/22 23:30
Wormhole’s W token enters ‘value accrual’ phase with strategic reserve

Wormhole’s W token enters ‘value accrual’ phase with strategic reserve

Wormhole has moved beyond its distribution phase, initiating a new strategy. By allocating on-chain and off-chain protocol revenue to a dedicated treasury, the cross-chain protocol is creating a direct link between its commercial success and the value of its native…
Share
Crypto.news2025/09/18 03:05
Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

The post Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto appeared on BitcoinEthereumNews.com. Advertisement &nbsp &nbsp Forward Industries, the largest publicly traded Solana treasury company, has filed a $4 billion at-the-market (ATM) equity offering program with the U.S. SEC  to raise more capital for additional SOL accumulation. Forward Strategies Doubles Down On Solana Strategy In a Wednesday press release, Forward Industries revealed that the 4 billion ATM equity offering program will allow the company to issue and sell common stock via Cantor Fitzgerald under a sales agreement dated Sept. 16, 2025. Forward said proceeds will go toward “general corporate purposes,” including the pursuit of its Solana balance sheet and purchases of income-generating assets. The sales of the shares are covered by an automatic shelf registration statement filed with the US Securities and Exchange Commission that is already effective – meaning the shares will be tradable once they’re sold. An automatic shelf registration allows certain publicly listed companies to raise capital with flexibility swiftly.  Kyle Samani, Forward’s chairman, astutely described the ATM offering as “a flexible and efficient mechanism” to raise and deploy capital for the company’s Solana strategy and bolster its balance sheet.  Advertisement &nbsp Though the maximum amount is listed as $4 billion, the firm indicated that sales may or may not occur depending on existing market conditions. “The ATM Program enhances our ability to continue scaling that position, strengthen our balance sheet, and pursue growth initiatives in alignment with our long-term vision,” Samani said. Forward Industries kicked off its Solana treasury strategy on Sept. 8. The Wednesday S-3 form follows Forward’s $1.65 billion private investment in public equity that closed last week, led by crypto heavyweights like Galaxy Digital, Jump Crypto, and Multicoin Capital. The company started deploying that capital this week, announcing it snatched up 6.8 million SOL for approximately $1.58 billion at an average price of $232…
Share
BitcoinEthereumNews2025/09/18 03:42